Tao Pei, Ph.D.

Group Vice President, Chemistry at Arrowhead Pharmaceuticals

Speaker

Dr. Tao Pei is the Senior VP of Discovery Chemistry at Arrowhead Pharmaceuticals. In this role, he leads multiple function groups in the exploration and development of TRiM™ platforms to several extrahepatic tissues including lung, skeletal muscle, adipose, and CNS. Tao is a key architect of Arrowhead’s TRiM™ technology and contributor to the final design of Arrowhead’s first TRiM™ candidate, Olpasiran—now in Phase III clinical trials.

Prior to Arrowhead, Tao was at Merck Process Research and Merck Sirna. There, he contributed to the final API chemistry of Merck’s Grazoprevir which has been approved to treat Hepatitis C.

Tao earned his PhD in chemistry from Duke University where he performed research in Dr. Ross Widenhoefer’s lab.